No one can save on patients. They also get the medicines they need. This was declared by the Minister of Health Kamil Šaško (voice-SD) in response to a wave of criticism of the new Decree to Drug Policy, which the resort submitted to the interdepartmental comment procedure.
Declared that his only goal is to set JASSIAL AND Objective rules to enter new medicines into the reimbursement system so that The system was predictable, balanced and sustainable.
“Dear patients, You don’t have to worry about anything. You don’t have to worry about losing treatment or medication. On the contrary, the point is to make money wisely and everyone, but indeed anyone who needs the medicine, To really get it. But, and this is very important at prices that are at least comparable to the neighboring countries, ”said Šaško in the video sent by TASR from the Ministry of Health (MZ) SR.
According to Minister, the current system is unsustainable and opaque, The resources intended for patients are used inefficiently and waste them. He recalled that the Supreme Audit Office of the Slovak Republic also drew attention to the functioning of the system. “So really my only interest is that these sources are directed effectively if our patients. NEMLY else.
Because the resources we pass in this way are then lacking in other areas of health care, for example in our outpatient sector‘Said the clown. The minister assured that no one can sew anything with a hot needle. “At this point, it is primarily about opening a factual and professional discussion to actually fromAssay issue of the entry of new drugs for Slovak patients, ” added.
The Ministry of Health proposes a change in the conditions for the entry of new medicines into the system of reimbursement from public health insurance. The resort pointed out that at current rules calculating their cost efficiency would have not been sufficient for medicines earmarked for medicines this year.
They are therefore therefore having a edit the decreewhich is in a shortened interdepartmental comment procedure. The Ministry has guessed that this could be saved in the reimbursement for the least in five years EUR 583 million. Proposal It criticizes the opposition and professional and patient companies. They warn that it will worsen or prevent the access of Slovak patients to drugs.
